Evidence map›Paper›PMID 19770623›Full record

Trial reportAIDS (London, England)2009

Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters).

Godfrey Kigozi, Maria Wawer, Absalom Ssettuba, Joseph Kagaayi, Fred Nalugoda, Stephen Watya, Fred Wabwire Mangen, Noah Kiwanuka, Melanie C Bacon, Tom Lutalo and 2 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03412071 (Testing the Ability of a Microbiome - Focused Intervention to Reduce HIV Susceptibility in Ugandan Men), which is not on this map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03412071 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Testing the Ability of a Microbiome - Focused Intervention to Reduce HIV Susceptibility in Ugandan Men

TypeinterventionalSponsorUniversity of TorontoRan2017 to 2019Enrolled125ConditionsForeskin HIV SusceptibilityArmsOral Tinidazole, Topical metronidazole, Topical Clindamycin, Topical Hydrogen Peroxide
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. HIV Transmission and Immunology of the Male Reproductive Tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Godfrey KigoziRakai Health Sciences Program, Entebbe, Uganda. gkigozi@rhsp.org
Maria Wawer
Absalom Ssettuba
Joseph Kagaayi
Fred Nalugoda
Stephen Watya
Fred Wabwire Mangen
Noah Kiwanuka
Melanie C Bacon
Tom Lutalo
David Serwadda
Ronald H Gray
Makerere University · UGRakai Health Sciences Program · UGJohns Hopkins University · USGTx (United States) · USMulago Hospital · UGNational Institute of Allergy and Infectious Diseases · USUganda Virus Research Institute · UG

Funding

Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
NIAID NIH HHS U01 AI051171NIAID NIH HHS U1AI51171
6 · The paper itself

Abstract

introductionMale circumcision reduces HIV acquisition in men. We assessed whether foreskin surface area was associated with HIV acquisition prior to circumcision.

methodsIn two randomized trials of male circumcision, the surface area of the foreskin was measured after surgery using standardized procedures. Nine hundred and sixty-five initially HIV-negative men were enrolled in a community cohort who subsequently enrolled in the male circumcision trials, provided 3920.8 person-years of observation prior to circumcision. We estimated HIV incidence per 100 person-years prior to circumcision, associated with foreskin surface area categorized into quartiles.

resultsMean foreskin surface area was significantly higher among men who acquired HIV (43.3 cm2, standard error 2.1) compared with men who remained uninfected (36.8 cm, standard error 0.5, P = 0.01). HIV incidence was 0.80/100 person-years (8/994.9 person-years) for men with foreskin surface areas in the lowest quartile (< or =26.3 cm2), 0.92/100 person-years (9/975.3 person-years) with foreskin areas in the second quartile (26.4-35.0 cm2), 0.90/100 person-years (8/888.5 person-years) with foreskin area in the third quartile (35.2-45.5 cm2) and 2.48/100 person-years (23/926.8 person-years) in men with foreskin surfaces areas in the highest quartile (>45.6 cm2). Compared with men with foreskin surface areas in the lowest quartile, the adjusted incidence rate ratio of HIV acquisition was 2.37 (95% confidence interval 1.05-5.31) in men with the largest quartile of foreskin surface area.

conclusionThe risk of male HIV acquisition is increased among men with larger foreskin surface areas.

Indexed as

Circumcision, MaleAdolescentAdultForeskinHIV-1HIV InfectionsHumansMaleMiddle AgedUgandaViral LoadYoung Adult

Identifiers

PMID19770623
PMCPMC3125976
OpenAlexW2162401054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.